Albany Cancer Center - Patroon Creek office has reopened. Use lower lot entrance for all appointments.
Albany Medical Center patients should continue to use upper lot entrance to check in for appointments in Suite 210.
Radiation, PET and CT patients use radiation entrance in lower lot. Learn More

Clinical Trials & Research

Ph 3 Tuca/Placbo + T-DM1 HER2+

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (HER2CLIMB-02)(SGNTUC-016)

Disease Types: Breast,&nbs

Available at: {clinical_trial_location backspace="7"}Ph 3 Tuca/Placbo + T-DM1 HER2+, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}